A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101)
| Image |  |
|---|---|
| Description | scientific article published on 19 July 2018 |
| Author/s |
author: Hajime Asahina |
| Publication date | July 19, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |